These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
It has been built at a cost of Rs 19.5 crores through internal accruals of the Malabar Institute of Medical Sciences (MIMS)
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
The three-dose vaccine approved for EUA contains 2mg for each dose, whereas the two-dose plan will have 3mg in each dose.
The hospital through its network performs more than 10,000 joint replacement surgeries annually
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
Subscribe To Our Newsletter & Stay Updated
